These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2889601)

  • 1. Potential role of somatostatin analogues in the treatment of cancer.
    Lamberts SW; Koper JW; Reubi JC
    Eur J Clin Invest; 1987 Aug; 17(4):281-7. PubMed ID: 2889601
    [No Abstract]   [Full Text] [Related]  

  • 2. Future aspects of somatostatin-receptor-mediated therapy.
    Oberg K
    Neuroendocrinology; 2004; 80 Suppl 1():57-61. PubMed ID: 15477719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review: long-acting somatostatin analogues.
    Long RG
    Aliment Pharmacol Ther; 1987 Jun; 1(3):191-200. PubMed ID: 2908749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours.
    Modlin IM; Pavel M; Kidd M; Gustafsson BI
    Aliment Pharmacol Ther; 2010 Jan; 31(2):169-88. PubMed ID: 19845567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological studies of somatostatin and somatostatin-analogues: therapeutic advances and perspectives.
    Moreau JP; DeFeudis FV
    Life Sci; 1987 Feb; 40(5):419-37. PubMed ID: 2880272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of somatostatin receptors for diagnosis and therapy of endocrine pancreatic tumors].
    Schusdziarra V
    Z Gastroenterol; 1991 Jul; 29(7):363-4. PubMed ID: 1659049
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple actions of somatostatin in neoplastic disease.
    Reubi JC; Laissue JA
    Trends Pharmacol Sci; 1995 Mar; 16(3):110-5. PubMed ID: 7792931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of somatostatin analogs in the management of non-functioning neuroendocrine tumors.
    Pivonello R; Ferone D; Filippella M; Faggiano A; De Martino MC; Auriemma RS; Rota F; Lombardi G; Colao A
    J Endocrinol Invest; 2003; 26(8 Suppl):82-8. PubMed ID: 15233220
    [No Abstract]   [Full Text] [Related]  

  • 9. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer].
    Hofsli E
    Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future.
    Öberg K; Lamberts SW
    Endocr Relat Cancer; 2016 Dec; 23(12):R551-R566. PubMed ID: 27697899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The puzzle of somatostatin: action, receptors, analogues and therapy.
    Panteris V; Karamanolis DG
    Hepatogastroenterology; 2005; 52(66):1771-81. PubMed ID: 16334776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution of synthetic somatostatin analogues to the clinical features of gastroenteropancreatic endocrine tumors].
    Biliotti G
    G Chir; 2006 Apr; 27(4):129-31. PubMed ID: 16768865
    [No Abstract]   [Full Text] [Related]  

  • 13. Somatostatin analogs in the management of gastrointestinal tumors.
    Lamberts SW
    Horm Res; 1988; 29(2-3):118-20. PubMed ID: 2900191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Somatostatin analogues for the treatment of gastro-entero-pancreatic neuroendocrine tumours].
    Uomo G; Germano D; Rabitti PG
    Minerva Endocrinol; 2001 Dec; 26(4):225-9. PubMed ID: 11782707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin analogs in the treatment of acromegaly.
    Lamberts SW; Reubi JC; Krenning EP
    Endocrinol Metab Clin North Am; 1992 Sep; 21(3):737-52. PubMed ID: 1355729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiproliferative effect of somatostatin analogs: clinical relevance in patients with neuroendocrine gastro-entero-pancreatic tumours.
    Verslype C; Carton S; Borbath I; Delaunoit T; Demetter P; Demolin G; Hendlisz A; Pattyn P; Pauwels S; Peeters M; Roeyen G; Van Hootegem P; Van Laethem JL; Van Cutsem E
    Acta Gastroenterol Belg; 2009; 72(1):54-8. PubMed ID: 19402373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion.
    Williams G; Anderson JV; Williams SJ; Bloom SR
    Acta Endocrinol Suppl (Copenh); 1987; 286():26-36. PubMed ID: 2892335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical applications of somatostatin analogs.
    Marbach P; Neufeld M; Pless J
    Adv Exp Med Biol; 1985; 188():339-53. PubMed ID: 2863941
    [No Abstract]   [Full Text] [Related]  

  • 19. Somatostatin and analogues in the treatment of cancer. A review.
    Evers BM; Parekh D; Townsend CM; Thompson JC
    Ann Surg; 1991 Mar; 213(3):190-8. PubMed ID: 1671812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin analogues in functioning gastroenteropancreatic neuroendocrine tumours: literature review, clinical recommendations and schedules.
    Massironi S; Conte D; Rossi RE
    Scand J Gastroenterol; 2016; 51(5):513-23. PubMed ID: 26605828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.